Yamashita TE - Search Results

1

Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.

Giorgi JV, Lyles RH, Matud JL, Yamashita TE, Mellors JW, Hultin LE, Jamieson BD, Margolick JB, Rinaldo CR Jr, Phair JP, Detels R; Multicenter AIDS Cohort Study. Giorgi JV, et al. Among authors: yamashita te. J Acquir Immune Defic Syndr. 2002 Apr 1;29(4):346-55. doi: 10.1097/00126334-200204010-00004. J Acquir Immune Defic Syndr. 2002. PMID: 11917238

2

Persistent GB virus C infection and survival in HIV-infected men.

Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, Liu C, Phair J, Margolick JB, Zdunek D, Hess G, Stapleton JT. Williams CF, et al. Among authors: yamashita te. N Engl J Med. 2004 Mar 4;350(10):981-90. doi: 10.1056/NEJMoa030107. N Engl J Med. 2004. PMID: 14999110 Free article.

3

Virologic and immunologic response to highly active antiretroviral therapy.

Jacobson LP, Phair JP, Yamashita TE. Jacobson LP, et al. Among authors: yamashita te. Curr HIV/AIDS Rep. 2004 Jun;1(2):74-81. doi: 10.1007/s11904-004-0011-1. Curr HIV/AIDS Rep. 2004. PMID: 16091226 Review.

4

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

Lyles RH, Muñoz A, Yamashita TE, Bazmi H, Detels R, Rinaldo CR, Margolick JB, Phair JP, Mellors JW. Lyles RH, et al. Among authors: yamashita te. J Infect Dis. 2000 Mar;181(3):872-80. doi: 10.1086/315339. J Infect Dis. 2000. PMID: 10720507

5

Virologic and Immunologic Response to Highly Active Antiretroviral Therapy.

Jacobson LP, Phair JP, Yamashita TE. Jacobson LP, et al. Among authors: yamashita te. Curr Infect Dis Rep. 2002 Feb;4(1):88-96. doi: 10.1007/s11908-002-0072-5. Curr Infect Dis Rep. 2002. PMID: 11853662

6

When to initiate highly active antiretroviral therapy: a cohort approach.

Ahdieh-Grant L, Yamashita TE, Phair JP, Detels R, Wolinsky SM, Margolick JB, Rinaldo CR, Jacobson LP. Ahdieh-Grant L, et al. Among authors: yamashita te. Am J Epidemiol. 2003 Apr 15;157(8):738-46. doi: 10.1093/aje/kwg036. Am J Epidemiol. 2003. PMID: 12697578

7

Update on the Virologic and Immunologic Response to Highly Active Antiretroviral Therapy.

Jacobson LP, Phair JP, Yamashita TE. Jacobson LP, et al. Among authors: yamashita te. Curr Infect Dis Rep. 2004 Aug;6(4):325-332. doi: 10.1007/s11908-004-0055-9. Curr Infect Dis Rep. 2004. PMID: 15265462

8

Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study.

Jacobson LP, Yamashita TE, Detels R, Margolick JB, Chmiel JS, Kingsley LA, Melnick S, Muñoz A. Jacobson LP, et al. Among authors: yamashita te. J Acquir Immune Defic Syndr. 1999 Aug 1;21 Suppl 1:S34-41. J Acquir Immune Defic Syndr. 1999. PMID: 10430217

9

Immunologic and virologic response to highly active antiretroviral therapy in the Multicenter AIDS Cohort Study.

Yamashita TE, Phair JP, Muñoz A, Margolick JB, Detels R, O'Brien SJ, Mellors JW, Wolinsky SM, Jacobson LP. Yamashita TE, et al. AIDS. 2001 Apr 13;15(6):735-46. doi: 10.1097/00002030-200104130-00009. AIDS. 2001. PMID: 11371688 Clinical Trial.

10

Individual variation in CD4 cell count trajectory among human immunodeficiency virus-infected men and women on long-term highly active antiretroviral therapy: an application using a Bayesian random change-point model.

Chu H, Gange SJ, Yamashita TE, Hoover DR, Chmiel JS, Margolick JB, Jacobson LP. Chu H, et al. Among authors: yamashita te. Am J Epidemiol. 2005 Oct 15;162(8):787-97. doi: 10.1093/aje/kwi268. Epub 2005 Aug 31. Am J Epidemiol. 2005. PMID: 16135508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page